Home » Stocks » AXLA

Axcella Health, Inc. (AXLA)

Stock Price: $4.40 USD -0.35 (-7.37%)
Updated Oct 28, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 160.37M
Revenue (ttm) n/a
Net Income (ttm) -61.92M
Shares Out 36.45M
EPS (ttm) -2.51
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 28, 2020
Last Price $4.40
Previous Close $4.75
Change ($) -0.35
Change (%) -7.37%
Day's Open 4.75
Day's Range 4.32 - 4.75
Day's Volume 88,702
52-Week Range 2.25 - 7.73

More Stats

Market Cap 160.37M
Enterprise Value 64.12M
Earnings Date (est) Nov 17, 2020
Ex-Dividend Date n/a
Shares Outstanding 36.45M
Float 14.19M
EPS (basic) -2.42
EPS (diluted) -2.51
FCF / Share -1.87
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 378,354
Short Ratio 2.69
Short % of Float 2.67%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 1.76
Revenue n/a
Operating Income -59.98M
Net Income -61.92M
Free Cash Flow -54.69M
Net Cash 96.25M
Net Cash / Share 2.64
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -30.36%
ROE -67.70%
ROIC -306.30%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (8)

Buy 7
Overweight 0
Hold 1
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(232.27% upside)
Current: $4.40
Target: 14.62
*Average 12-month price target from 8 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Operating Income-57.44-33.90-28.92
Net Income-59.04-36.07-30.94
Shares Outstanding16.624.554.21
Earnings Per Share-3.55-7.97-7.37
Operating Cash Flow-50.96-30.71-26.86
Capital Expenditures-0.12-0.59-0.92
Free Cash Flow-51.08-31.30-27.78
Cash & Equivalents92.0579.4746.82
Total Debt24.9024.5219.56
Net Cash / Debt67.1654.9527.26
Book Value60.22-150-116
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Axcella Health, Inc.
Country United States
Employees 69
CEO William R. Hinshaw

Stock Information

Ticker Symbol AXLA
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: AXLA
IPO Date May 9, 2019


Axcella Health, a clinical-stage biotechnology company, researches and develops endogenous metabolic modulators (EMMs) for the treatment of complex diseases and improving health in the United States. It offers AXA1665 for use in treating overt hepatic encephalopathy; AXA1125 and AXA1957 to treat non-alcoholic steatohepatitis; AXA2678 for use in treating muscle atrophy; and AXA4010 to target multiple biological pathways to support normal structures and functions of the blood. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was founded in 2008 and is based in Cambridge, Massachusetts.